Drugs / Astrix
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01765452 Comparator | Oct 2012 → Aug 2013 | coronary artery disorder | HK inno.N Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Astrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01765452 ↗ |
| Route | Oral | “75mg, 100mg a day, 8weeks, PO” NCT01765452 ↗ |